Xi'an Zhouliangmingkang Biomedical Technology Co., Ltd.

1. Using the improvement of breast pain, the change of breast mass size and the improvement of TCM symptoms as efficacy indicators, the effectiveness of Shengruling Capsules in treating breast hyperplasia (liver depression and phlegm stagnation syndrome) was preliminarily evaluated, and a dose exploration study was conducted at the same time. 2. The safety of the clinical application of Shengruling Capsules was evaluated through the observation of clinical adverse events.

1. To evaluate the clinical efficacy of Likang Fuyan Suppository in the treatment of vulvovaginal candidiasis (damp-heat syndrome) by taking the improvement of clinical symptoms and signs, mycological evaluation results, comprehensive efficacy evaluation results and improvement of TCM syndrome as efficacy indicators. 2. To evaluate the safety of Likang Fuyan Suppository in clinical application through clinical adverse event observation.

1. Preliminary evaluation of the safety and effectiveness of Tongnao Thrombolysis Capsules in the treatment of cerebral infarction recovery period (Qi deficiency and blood stasis syndrome). 2. Based on the clinical dose and course of treatment proposed in this plan, the final Phase III clinical drug dose and course of treatment were determined.